Immunological Properties of Monoclonal Antibodies Specific for Meningococcal Polysaccharides: the Protective Capacity of IgM Antibodies Specific for Polysaccharide Group B
Two IgM monoclonal antibodies, MB32 and MB34 specific for meningococcal polysaccharide group B have been raised. Both were detectable by radioimmunoassay and agglutination, but only MB34 was effective in counter immunoelectrophoresis and complement fixation. MB34 was also far more potent than MB32 when tested for passive protection of mice infected with either Neisseria meningitidis group B or Escherichia coli K1. These data demonstrate that group B-specific antibodies do play a protective role in mice infected with these bacteria.
AdlamC., ScottM.T.1973; Lympho-reticular stimulatory properties of Corynebacterium parvum and related bacteria. Journal of Medical Microbiology 6:261–273
BhattacharjeeA.K., JenningsH.J., KennyC.P., MartinA., SmithI.C.P.1975; Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with C13 nuclear magnetic resonance. Journal of Biological Chemistry 250:1926–1932
BrilesD.E., ClafinJ.L., SchroerK., FormanC.1981a; Mouse IgG3 antibodies are highly protective against infection with Streptococcus pneumoniae. Nature, London 294:88–90
BrilesD.E., NahmM., SchroerK., DavieJ., BakerP., KearneyJ., BarlettaR.1981b; Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. Journal of Experimental Medicine 153:694–705
BortolussiR., FerrieriP.1980; Protection against Escherichia coli K1. Infection in newborn rats by antibody to K1 capsular polysaccharide antigen. Infection and Immunity 28:111–117
CalverG.A., KennyC.P., LavergneG.1976; Iron as a replacement for mucin in the establishment of meningococcal infection in mice. Canadian Journal of Microbiology 22:832–838
CoatesA.R.M., HewittJ., AllenB.W., IvanyiJ., MitchisonD.A.1981; Antigenic diversity of Mycobacterium tuberculosis and Mycobacterium bovisdetected by means of monoclonal antibodies. Lancet 2:167–169
CountsG.W., TurckM.1977; Screening for cross-reactive capsular polysaccharide K antigens of Escherichia coli using antiserum agar. Journal of Clinical Microbiology 5:490–491
CravenD.E., FraschC.E.1979; Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse bacteremia model. Infection and Immunity 26:110–117
FraschC.E., ParkesL., McnelisR.M., GotschlichE.C.1976; Protection against group B meningococcal disease. I. Comparison of group-specific and type-specific protection in the chick embryo model. Journal of Experimental Medicine 144:319–329
GoldschneiderI., GotschlichE.C., ArtensteinM.S.1969; Human immunity to meningococcus. I. The role of humoral antibodies. Journal of Experimental Medicine 129:1307–1326
GotschlichE.C., ReyM., EtienneJ., SanbornW.R., TriauR., CvjetanovicB.1972; The immunological responses observed in field studies in Africa with group A meningococcal vaccines. Progress in lmmunobiological Standardization 5:485–491
GotschlichE.C., AustrianR., CvjetanovicB., RobbinsJ.B.1978; Prospects for prevention of bacterial meningitis with polysaccharide vaccines. Bulletin of the World Health Organization 56:509–518
HolbeinB.E., JerichoK.W., LikesG.C.1979; Neisseria meningitidis infection in mice: influence of iron, variations in virulence among strains and pathology. Infection and Immunity 24:545–551
KasperD.L., WinkelhakeJ.L., BrandtB.L., ArtensteinM.S.1973a; Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis. Journal of Infectious Diseases 127:378–387
KasperD.L., WinkelhakeJ.L., ZollingerW.D., BrandtB.L., ArtensteinM.S.1973b; Immunochemical similarity between polysaccharide antigens of E. coli 07:K1(L):NM and group B Neisseria meningitidis. Journal of Immunology 110:262–268
LifelyM.R., GilbertA.S., MorenoC.1981; Sialic acid polysaccharide antigens of Neisseria meningitidis and Escherichia coli: esterification between adjacent residues. Carbohydrate Research 94:193–203
MandrellR.E., ZollingerW.D.1982; Measurement of antibodies to meningococcal group B polysaccharides: low avidity and equilibrium binding constants. Journal of Immunology 129:2172–2178
StevensP., ShenaN-Y., HuaneD.W., YoungL.S.1978; Restricted complement activation by Escherichia coli with the K-l capsular serotype: a possible role in pathogenicity. Journal of Immunology 121:2174–2180
StevensP., ChuC.L., YoungL.S.1980; K-l antigen content and the presence of an additional sialic acid-containing antigen among bacteremic K-l Escherichia coli: correlation with susceptibility to opsonophagocytosis. Infection and Immunity 29:1055–1061
WyleF.A., ArtensteinM.S., BrandtB.L., TramontE.C., KasperD.L., AltieriP.L., BermanS.L., LowenthalJ.P.1972; Immunologic response of man to group B meningococcal polysaccharide vaccines. Journal of Infectious Disease 126:514–522
Immunological Properties of Monoclonal Antibodies Specific for Meningococcal Polysaccharides: the Protective Capacity of IgM Antibodies Specific for Polysaccharide Group B